3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Carcinoma, Ovarian Epithelial
1
Interventions
Paclitaxel
18
Carboplatin
14
Topotecan
8
liposomal doxorubicin
6
Cyclophosphamide
5
Cisplatin
5
Gemcitabine
4
Docetaxel
4
oregovomab
3
Immunoenzyme Techniques
3
Etoposide
3
Capecitabine
3
pembrolizumab
2
fludarabine phosphate
2
aldesleukin
2
Taxes
2
Surgical Procedures, Operative
2
Stem Cell Transplantation
2
STA 9090
2
Peripheral Blood Stem Cell Transplantation
2
Oxaliplatin
2
Nivolumab
2
Microarray Analysis
2
Magnetic Resonance Spectroscopy
2
Lenalidomide
2
Fulvestrant
2
Fluorodeoxyglucose F18
2
Flow Cytometry
2
Filgrastim
2
Cytoreduction Surgical Procedures
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Carcinoma, Ovarian Epithelial
×
CCV-AV protocol
×
Clear all
NCT01521143
2016-12-14
CANVAS
Prima BioMed Ltd
Phase 2
Terminated
91 enrolled
5 charts